Affinity Apheresis for Treatment of Bacteremia Caused by Staphylococcus aureus and/or Methicillin-Resistant S. aureus (MRSA)
![]() |
Mattsby-Baltzer, Inger
(Department of Infectious Diseases/Clinical Bacteriology, University of Gothenburg)
Bergstrom, Tomas (Department of Infectious Diseases/Clinical Virology, University of Gothenburg) Mccrea, Keith (Emergence LLC) Ward, Robert (Emergence LLC) Msc, Lars Adolfsson (ExThera AB, Karolinska Science Park) Larm, Olle (ExThera AB, Karolinska Science Park) |
1 | Axelsson, J., M. Ferreira, L. Adolfsson, K. McCrea, R. Ward, and O. Larm. 2010. Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J. 56: 48-51. DOI ScienceOn |
2 | Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30: 1654-1660. |
3 | Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7: 401-420. |
4 | Cai, B., E. A. Deitch, and L. Ulloa. 2010. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462. |
5 | Carleton, H. A., B. A. Diep, E. D. Charlebois, G. F. Sensabaugh, and F. Perdreau-Remington. 2004. Community-adapted methicillinresistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. 190: 1730-1738. DOI ScienceOn |
6 | Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. 36: 53-59. DOI ScienceOn |
7 | Liang, O. D., F. Ascencio, L. A. Fransson, and T. Wadstrom. 1992. Binding of heparan sulfate to Staphylococcus aureus. Infect. Immun. 60: 899-906. |
8 | Liang, O. D., F. Ascencio, R. Vazquezjuarez, and T. Wadstrom. 1993. Binding of collagen, fibronectin, lactoferrin, laminin, vitronectin and heparan-sulfate to Staphylococcus aureus strain- V8 at various growth phases and under nutrient stress conditions. Zentralbl. Bakteriol. Microbiol. Hyg. A 279: 180-190. DOI ScienceOn |
9 | Lisboa, T., G. Waterer, and J. Rello. 2010. We should be measuring genomic bacterial load and virulence factors. Crit. Care Med. 38: S656-S662. DOI |
10 | Ljungh, A. and T. Wadstrom. 1995. Growth-conditions influence expression of cell-surface hydrophobicity of staphylococci and other wound-infection pathogens. Microbiol. Immunol. 39: 753- 757. DOI |
11 | Lowy, F. D. 1998. Staphylococcus aureus infections. N Engl. J. Med. 339: 520-532. DOI ScienceOn |
12 | Olofsson, S. and T. Bergstrom. 2005. Glycoconjugate glycans as viral receptors. Ann. Med. 37: 154-172. DOI ScienceOn |
13 | Ovstebo, R., P. Brandtzaeg, B. Brusletto, K. B. Haug, K. Lande, E. A. Hoiby, and P. Kierulf. 2004. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J. Clin. Microbiol. 42: 2980-2987. DOI ScienceOn |
14 | Payen, D., J. Mateo, J. M. Cavaillon, F. Fraisse, C. Floriot, and E. Vicaut. 2009. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit. Care Med. 37: 803-810. DOI ScienceOn |
15 | Hsu, R. B. 2005. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26: 654-657. DOI ScienceOn |
16 | Jessen, M. E. 2006. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesth. Analg. 103: 1365-1369. DOI ScienceOn |
17 | Kollef, M. H. 2000. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4): S131-S138. |
18 | Lala, H. M., G. D. Mills, K. Barratt, J. Bonning, N. E. Manikkam, and D. Martin. 2007. Meningococcal disease deaths and the frequency of antibiotic administration delays. J. Infect. 54: 551-557. DOI ScienceOn |
19 | Larm, O., R. Larsson, and P. Olsson. 1983. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11: 161-173. |
20 | Tetta, C., V. D'Intini, R. Bellomo, M. Bonello, V. Bordoni, Z. Ricci, and C. Ronco. 2003. Extracorporeal treatments in sepsis: Are there new perspectives? Clin. Nephrol. 60: 299-304. |
21 | David, M. Z. and R. S. Daum. 2010. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23: 616-687. DOI ScienceOn |
22 | Hackett, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child. 86: 44-46. DOI ScienceOn |
23 | Hess, D. J., M. J. Henry-Stanley, S. L. Erlandsen, and C. L. Wells. 2006. Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. 195: 133-141. DOI ScienceOn |
24 | Wadstrom, T. and A. Ljungh. 1999. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J. Med. Microbiol. 48: 223-233. DOI ScienceOn |
25 | Valente, A. M., R. Jain, M. Scheurer, V. G. Fowler Jr., G. R. Corey, A. R. Bengur, S. Sanders, and J. S. Li. 2005. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115: e15-e19. |
26 | van der Poll, T. and S. M. Opal. 2008. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8: 32-43. DOI ScienceOn |
27 | van Haeften, R., S. Palladino, I. Kay, T. Keil, C. Heath, and G. W. Waterer. 2003. A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn. Microbiol. Infect. Dis. 47: 407-414. DOI ScienceOn |
28 | Venkataraman, R., S. Subramanian, and J. A. Kellum. 2003. Clinical review: Extracorporeal blood purification in severe sepsis. Crit. Care 7: 139-145. DOI ScienceOn |
29 | Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317. DOI ScienceOn |
30 | Pertosa, G., G. Grandaliano, L. Gesualdo, and F. P. Schena. 2000. Clinical relevance of cytokine production in hemodialysis. Kidney Int. 76: S104-S111. |
31 | Peters, R. P., M. A. van Agtmael, S. Gierveld, S. A. Danner, A. B. Groeneveld, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2007. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin. Microbiol. 45: 3641- 3646. DOI ScienceOn |
32 | Rello, J., T. Lisboa, M. Lujan, M. Gallego, C. Kee, I. Kay, D. Lopez, and G. W. Waterer. 2009. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136: 832-840. DOI ScienceOn |
33 | Riesenfeld, J. and L. Roden. 1990. Quantitative analysis of Nsulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Anal. Biochem. 188: 383-389. DOI ScienceOn |
34 | Ronco, C., R. Bellomo, P. Homel, A. Brendolan, M. Dan, P. Piccinni, and G. La Greca. 2000. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30. DOI ScienceOn |
35 | Schefold, J. C., S. von Haehling, M. Corsepius, C. Pohle, P. Kruschke, H. Zuckermann, H. D. Volk, and P. Reinke. 2007. A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complementactivating product 5a. Shock 28: 418-425. DOI ScienceOn |
36 | Segreti, J. 2005. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin. Microbiol. Infect. 11 (Suppl 3): 29-35. DOI |
37 | Tang, L. and J. W. Eaton. 1995. Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103: 466-471. |
![]() |